Barrister specialising in intellectual property law, with a particular emphasis on technically complex patent cases in biotechnology, pharmaceuticals, telecoms and electronics. Scheduled trials include Orderly Mind v QueueIt (website queueing), Mara v DSM (algal fatty acid production), Samsung BioEpis v Alexion (antibody drug), Hill v Touchlight (DNA production). Recent cases include Abbott v DexCom (glucose sensors), Gilead v NuCana (nucleoside derivatives), InterDigital v Lenovo (telecoms), Optis v Apple (telecoms), Insulet v Roche (insulin pumps), Royalty Pharma v Boehringer Ingelheim (royalty dispute under German law), GSK v Fibrogen (iron deficiency drugs; settled shortly before trial), Conversant v Huawei (telecoms), Illumina v Ariosa (cell-free foetal DNA enrichment), Silence v Alnylam (RNAi; settled shortly before trial), Pacific Biosciences v Oxford Nanopore (DNA sequencing; settled shortly before trial), Illumina v Premaitha (prenatal diagnosis), Regeneron v Kymab (antibody engineering).
Called 2005, Lincoln's Inn.
Chancery Bar Association, IP Bar Association.
BA in Natural Sciences (1st), Cambridge; PhD in molecular cell biology, Cambridge; postgraduate diploma in law (distinction), City University; bar vocational course (outstanding), BPP.